tradingkey.logo

Shanghai Henlius Biotech Inc Says U.S. FDA Approves HLX14 Products For Eight Indications

ReutersSep 1, 2025 3:39 PM

- Shanghai Henlius Biotech Inc 2696.HK:

  • U.S. FDA APPROVES HLX14 PRODUCTS FOR EIGHT INDICATIONS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI